Compass Therapeutics, Inc.
CMPX
$5.28
$0.061.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M |
| Total Depreciation and Amortization | 371.00K | 367.00K | 364.00K | 359.00K | 465.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 863.00K | 2.66M | 2.54M | 1.97M | 1.92M |
| Change in Net Operating Assets | 2.18M | 5.02M | 521.00K | 3.54M | -2.96M |
| Cash from Operations | -10.85M | -11.83M | -13.21M | -9.16M | -11.05M |
| Capital Expenditure | -7.00K | 0.00 | -18.00K | 0.00 | -44.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.15M | -6.36M | 11.61M | 15.37M | 29.06M |
| Cash from Investing | -95.16M | -6.36M | 11.59M | 15.37M | 29.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 138.00M | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | -815.00K | -96.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.64M | -- | -- | 2.00K | -2.00K |
| Cash from Financing | 129.36M | 0.00 | -815.00K | -94.00K | -2.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.36M | -18.19M | -2.44M | 6.11M | 17.97M |